News

BioStat® Research
& Development Centre

2024 2023 2022 older
Biostat 6th consecutive year as research and development center
18
October
2024
Biostat 6th consecutive year as research and development center
The Minister of Development and Technology has decided to maintain Biostat's status as a research and development...
Study on generalized myasthenia gravis for AstraZeneca
09
October
2024
Study on generalized myasthenia gravis for AstraZeneca
The Biostat Research and Development Center will carry out another project in collaboration with AstraZeneca. T...
Study of new solutions in surgery for Corza Medical
26
August
2024
Study of new solutions in surgery for Corza Medical
The Biostat Research and Development Center has signed an agreement with Corza Medical to conduct a PASS study in the...
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
21
August
2024
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
Marek Kluszczyński, MD, who specializes in the rehabilitation of children and adolescents, has published a scientific...
Biostat will conduct a medical experiment for Stallergenes Greer
17
July
2024
Biostat will conduct a medical experiment for Stallergenes Greer
Biostat Research and Development Center has signed an agreement with a pharmaceutical company Stallergenes Greer to c...
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
09
July
2024
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
The innovative CoolCryo® system for cardiac cryoablation, for which Biostat is conducting a clinical trial,...
Biostat will conduct a non-interventional study for Adamed Pharma
27
June
2024
Biostat will conduct a non-interventional study for Adamed Pharma
A non-interventional study among cardiology patients - this is a new field of cooperation between the Biostat R...
Biostat listed in the Forbes ranking
21
May
2024
Biostat listed in the Forbes ranking
For another year in a row, Biostat Research and Development Center has been recognized in the ranking of the most dyn...
Biostat and MSD Polska collaborate on lung cancer study
16
May
2024
Biostat and MSD Polska collaborate on lung cancer study
The Biostat Research and Development Centre starts cooperation with the MSD Polska pharmaceutical company. ...
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
01
March
2023
The launch of Medfile on the Norwegian market
01
March
2023

The launch of Medfile on the Norwegian market

The Medfile software is now available on the Norwegian market at medfile.no. The adaptation of the program for this market is a result of cooperation between Medfile SA and partner ViciData.

 

Medfile is comprehensive software for medical facilities, enabling electronic medical documentation, automation, and streamlining of work in clinics and doctor's offices, among other features. Almost all medical specialists can use Medfile. The software includes many advanced features, such as the ability to integrate with the institution's website, SMS notification module, VoIP telephony, fast payments, and access to medical databases and codes.

 

At the beginning of 2022, Medfile SA and ViciData signed an agreement aimed at implementing the Medfile program on the Norwegian market. Medfile was responsible for preparing and adapting the software, while ViciData was responsible for the legal and medical aspects of the project and the distribution of the product on the Norwegian market.

 

After a year of work, a service dedicated to medical doctors and specialists from Norway is now available at Medfile.no.

 

 

"The Medfile version for the Norwegian market is our first step towards adapting our software for Scandinavian markets. We are confident that these activities will translate into our expansion in all Western European countries. I would like to thank our partner, ViciData, for fruitful cooperation," commented Rafał Piszczek, CEO of Biostat and Medfile.

 

 

Currently, over 15,000 medical doctors in Poland use Medfile software. With the help of Medfile, doctors and specialists have conducted 15 million visits, served 4 million patients, and issued 3 million e-prescriptions. The program is integrated with the HaloDoctor telemedicine platform, contributing to the development of telemedicine in Poland.

 

Copyright© 2023 Biostat